Personalized intensification of treatment for hormone-sensitive prostate cancer.

Saved in:
Bibliographic Details
Title: Personalized intensification of treatment for hormone-sensitive prostate cancer.
Authors: Cilento MA; South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, South Australia, Australia.; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Butler LM; South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, South Australia, Australia., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Sweeney CJ; South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, South Australia, Australia. christopher.sweeney@adelaide.edu.au.; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. christopher.sweeney@adelaide.edu.au.
Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2026 Feb; Vol. 23 (2), pp. 121-136. Date of Electronic Publication: 2025 Nov 27.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1759-4782
DOI:10.1038/s41571-025-01100-3